RichardGBachMD
Cardiology • Saint Louis, MOInterventional Cardiology, Cardiac Critical Care
Professor of Medicine; Washington University Schoool of Medicine
Dr. Bach is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
Saint Louis, MO 63110Phone+1 314-362-1291Fax+1 314-362-4278
Education & Training
NYU Grossman School of MedicineFellowship, Cardiovascular Disease, 1988 - 1991- NYU Grossman School of MedicineResidency, Internal Medicine, 1984 - 1987
- New York University School of MedicineClass of 1984
Certifications & Licensure
OH State Medical License 2024 - 2026
MO State Medical License 1991 - 2025
IL State Medical License 1994 - 2023
NY State Medical License 1986 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2019
- Fellow (FAHA) American Heart Association
- Fellow (FSCAI) Society for Cardiovascular Angiography and Interventions
- Join now to see all
Publications & Presentations
PubMed
- 254 citationsThe Evolving Landscape of Impella® Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory SupportAmit P. Amin, John A. Spertus, Jeptha P. Curtis, Nihar R. Desai, Frederick A. Masoudi
Circulation. 2020-01-28 - 445 citationsMavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Artur Oreziak, Roberto Barriales-Villa, Theodore P. Abraham, Ahmad Masri
Lancet. 2020-09-12 - 140 citationsTicagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes A Substudy From the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PL...Steen Husted, Stefan James, Richard C. Becker, Jay Horrow, Hugo Katus
Circulation. Cardiovascular Quality and Outcomes. 2012-09-01
Press Mentions
- Effect of Simvastatin-Ezetimibe Compared with Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical TrialSeptember 1st, 2019
Intensive Lipid-Lowering Slashes CVD in Elderly ACS PatientsJuly 19th, 2019
Vytorin Benefit Greatest in Oldest PatientsJuly 18th, 2019- Join now to see all
Professional Memberships
- Member
- Fellow
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
